Year archive

AstraZeneca PLC — 2018 filings

All 226 regulatory filings released by AstraZeneca PLC (AZN) in 2018, sourced directly from the official regulator.

226 Filings

2018 Period

2018 filings (226)

Filing	Released	Lang
Annual Financial Report 2018 Annual Report FY 2018	2018-12-31	English
BEVESPI AEROSPHERE APPROVED IN THE EU FOR COPD Foreign Filer Report	2018-12-20	English
Bevespi Aerosphere approved in the EU for COPD Regulatory Filings	2018-12-20	English
LYNPARZA MEETS PRIMARY ENDPOINT IN SOLO-3 TRIAL Foreign Filer Report	2018-12-20	English
PHASE III ROCKIES AND OLYMPUS ROXADUSTAT TRIALS Foreign Filer Report	2018-12-20	English
Lynparza meets primary endpoint in SOLO-3 trial Regulatory Filings	2018-12-20	English
Phase III ROCKIES and OLYMPUS roxadustat trials Earnings Release FY 2018	2018-12-20	English
FDA APPROVES LYNPARZA AS 1L MAINTENANCE THERAPY Foreign Filer Report	2018-12-19	English
FDA approves Lynparza as 1L maintenance therapy Regulatory Filings	2018-12-19	English
ROXADUSTAT APPROVED IN CHINA FOR THE TREATMENT OF ANAEMIA IN CHRONIC KIDNEY DISE Foreign Filer Report	2018-12-18	English
Roxadustat approved in China for the treatment of Regulatory Filings	2018-12-18	English
DIRECTORATE CHANGE Foreign Filer Report	2018-12-14	English
Directorate Change Board/Management Information	2018-12-14	English
UPDATE ON THE PHASE III EAGLE TRIAL OF IMFINZI Foreign Filer Report	2018-12-07	English
Update on the Phase III EAGLE trial of Imfinzi Regulatory Filings	2018-12-07	English
DIVESTMENT OF RIGHTS TO COVIS COMPLETED Foreign Filer Report	2018-12-06	English
Divestment of rights to Covis completed M&A Activity	2018-12-06	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2018-12-04	English
Director/PDMR Shareholding Director's Dealing	2018-12-04	English
BLOCK LISTING INTERIM REVIEW Foreign Filer Report	2018-12-03	English
TOTAL VOTING RIGHTS Foreign Filer Report	2018-12-03	English
Block listing Interim Review Regulatory Filings	2018-12-03	English
Total Voting Rights Regulatory Filings	2018-12-03	English
GRUNENTHAL AGREEMENT FOR NEXIUM VIMOVO COMPLETED Foreign Filer Report	2018-12-03	English
Grünenthal Agreement for Nexium, Vimovo Completed M&A Activity	2018-12-03	English
US FDA GRANTS FASENRA ODD FOR EGPA Foreign Filer Report	2018-11-26	English
US FDA grants Fasenra ODD for EGPA Legal Proceedings Report	2018-11-26	English
Delisting Announcement 2018 Delisting Announcement	2018-11-16	English
Delisting Announcement 2018 Delisting Announcement	2018-11-16	English
ASTRAZENECA PROVIDES UPDATE ON PHASE III MYSTIC Foreign Filer Report	2018-11-16	English
AstraZeneca provides update on Phase III MYSTIC Regulatory Filings	2018-11-16	English
ASTRAZENECA TO DIVEST US SYNAGIS RIGHTS TO SOBI Foreign Filer Report	2018-11-13	English
US FDA ACCEPTS REGULATORY SUBMISSION FOR LYNPARZA Foreign Filer Report	2018-11-13	English
FARXIGA SIGNIFICANTLY REDUCED HOSPITALISATION FOR Foreign Filer Report	2018-11-13	English
AstraZeneca to divest US Synagis rights to Sobi Regulatory Filings	2018-11-13	English
US FDA accepts regulatory submission for Lynparza Legal Proceedings Report	2018-11-12	English
Farxiga significantly reduced hospitalisation for Regulatory Filings	2018-11-12	English
AZN: YEAR-TO-DATE AND Q3 2018 RESULTS Foreign Filer Report	2018-11-08	English
AZN: Year-to-Date and Q3 2018 Results Earnings Release 9M 2018	2018-11-08	English
DIVESTMENT OF RIGHTS TO COVIS PHARMA Foreign Filer Report	2018-11-06	English
Divestment of rights to Covis Pharma M&A Activity	2018-11-06	English
TOTAL VOTING RIGHTS Foreign Filer Report	2018-11-01	English
Total Voting Rights Regulatory Filings	2018-11-01	English
ADDITIONAL FINANCIAL INFORMATION-GRUNENTHAL DEAL Foreign Filer Report	2018-10-31	English
Additional financial information-Grünenthal deal Report Publication Announcement	2018-10-31	English
GRUNENTHAL AGREEMENT FOR RIGHTS TO NEXIUM VIMOVO Foreign Filer Report	2018-10-30	English
Grünenthal Agreement for rights to Nexium, Vimovo M&A Activity	2018-10-30	English
SC 13D Major Shareholding Notification	2018-10-29	English
FORM 4 SUBMISSION Director's Dealing	2018-10-24	English
ASTRAZENECA EXTENDS INNATE PHARMA COLLABORATION Foreign Filer Report	2018-10-23	English
AstraZeneca Extends Innate Pharma Collaboration M&A Activity	2018-10-23	English
LYNPARZA SHOWS 70% REDUCTION IN PFS OVARIAN CANCER Foreign Filer Report	2018-10-22	English
Lynparza shows 70% reduction in PFS ovarian cancer Regulatory Filings	2018-10-22	English
CHMP positive opinion Bevespi Aerosphere Legal Proceedings Report	2018-10-19	English
CHMP POSITIVE OPINION BEVESPI AEROSPHERE Foreign Filer Report	2018-10-19	English
FORM 3 SUBMISSION Director's Dealing	2018-10-18	English
FDA ORPHAN DRUG FOR LYNPARZA IN PANCREATIC CANCER Foreign Filer Report	2018-10-16	English
FDA Orphan Drug for Lynparza in pancreatic cancer Regulatory Filings	2018-10-16	English
SC 13D/A Major Shareholding Notification	2018-10-12	English
SC 13D Major Shareholding Notification	2018-10-05	English
FORM 4 SUBMISSION Director's Dealing	2018-10-03	English
TOTAL VOTING RIGHTS Foreign Filer Report	2018-10-01	English
Total Voting Rights Regulatory Filings	2018-10-01	English
ATACAND AGREEMENT WITH CHEPLAPHARM COMPLETED Foreign Filer Report	2018-10-01	English
Atacand Agreement with Cheplapharm Completed M&A Activity	2018-10-01	English
Previous Announcement Regarding Appointment Of NED Regulatory Filings	2018-09-28	English
PREVIOUS ANNOUNCEMENT REGARDING APPOINTMENT OF NED Foreign Filer Report	2018-09-28	English
FORM 3 SUBMISSION Director's Dealing	2018-09-26	English
Overall survival data for Imfinzi: Stage III NSCLC Regulatory Filings	2018-09-25	English
OVERALL SURVIVAL DATA FOR IMFINZI: STAGE III NSCLC Foreign Filer Report	2018-09-25	English
EMA approves AZ's Imfinzi for Stage III NSCLC Regulatory Filings	2018-09-24	English
EMA APPROVES AZ'S IMFINZI FOR STAGE III NSCLC Foreign Filer Report	2018-09-24	English
FARXIGA GETS POSITIVE RESULT IN DECLARE-TIMI 58 Foreign Filer Report	2018-09-24	English
Farxiga gets positive result in DECLARE-TIMI 58 Regulatory Filings	2018-09-24	English
FDA APPROVES AZS LUMOXITI IN HAIRY CELL LEUKAEMIA Foreign Filer Report	2018-09-14	English
TEZEPELUMAB FDA BREAKTHROUGH THERAPY DESIGNATION Foreign Filer Report	2018-09-07	English
Tezepelumab FDA Breakthrough Therapy Designation Regulatory Filings	2018-09-07	English
DIRECTORATE CHANGE Foreign Filer Report	2018-09-06	English
TOTAL VOTING RIGHTS Foreign Filer Report	2018-09-04	English
Total Voting Rights Regulatory Filings	2018-09-03	English
ASTRAZENECA UPDATE ON ANIFROLUMAB IN SLE Foreign Filer Report	2018-08-31	English
AstraZeneca Update on Anifrolumab in SLE Legal Proceedings Report	2018-08-31	English
EC APPROVES BYDUREON BCISE DEVICE FOR T2 DIABETES Foreign Filer Report	2018-08-30	English
EC approves Bydureon BCise device for T2 diabetes Regulatory Filings	2018-08-30	English
NYSE CERTIFICATION - ASTRAZENECA PLC Regulatory Filings	2018-08-23	English
ASTRAZENECA PIIIB TRIAL UPDATE FOR BEVESPI IN COPDASTRAZENECA PIIIB TRIAL UPDATE Foreign Filer Report	2018-08-23	English
AstraZeneca PIIIb trial update for Bevespi in COPD Regulatory Filings	2018-08-23	English
AZ'S TAGRISSO APPROVED IN JAPAN FOR 1ST-LINE NSCLC Foreign Filer Report	2018-08-21	English
AZ's Tagrisso approved in Japan for 1st-line NSCLC Regulatory Filings	2018-08-21	English
FORM 8-A12B Regulatory Filings	2018-08-17	English
FORM 6-K Foreign Filer Report	2018-08-17	English
FORM 424B2 Prospectus	2018-08-16	English
ASTRAZENECA PRICES A $3BN BOND ISSUE Foreign Filer Report	2018-08-15	English
AstraZeneca prices a $3bn bond issue Regulatory Filings	2018-08-15	English
FORM FWP Regulatory Filings	2018-08-15	English
S-8 Registration Form	2018-08-14	English
FORM FWP Regulatory Filings	2018-08-14	English
FORM 424B2 Prospectus	2018-08-14	English
6-K Foreign Filer Report	2018-08-10	English
EMA GRANTS OD FOR SELUMETINIB IN NF1 Foreign Filer Report	2018-08-03	English
EMA grants OD for selumetinib in NF1 Regulatory Filings	2018-08-03	English
TOTAL VOTING RIGHTS Foreign Filer Report	2018-08-01	English
Total Voting Rights Regulatory Filings	2018-08-01	English
CHMP RECOMMENDS IMFINZI FOR STAGE III NSCLC Foreign Filer Report	2018-07-27	English
CHMP recommends Imfinzi for Stage III nsclc Regulatory Filings	2018-07-27	English
6-K Foreign Filer Report	2018-07-26	English
AZN: H1 2018 Results Earnings Release H1 2018	2018-07-26	English
ATACAND TO BE DIVESTED TO CHEPLAPHARM IN EUROPE Foreign Filer Report	2018-07-24	English
Atacand to be divested to Cheplapharm in Europe Regulatory Filings	2018-07-24	English
Holding(s) in Company Major Shareholding Notification	2018-07-18	English
HOLDING(S) IN COMPANY Foreign Filer Report	2018-07-18	English
Regulatory Filings 2018 Regulatory Filings	2018-07-03	English
TOTAL VOTING RIGHTS Foreign Filer Report	2018-07-02	English
Total Voting Rights Regulatory Filings	2018-07-02	English
LYNPARZA APPROVED IN JAPAN FOR BRCAM BREAST CANCER Foreign Filer Report	2018-07-02	English
IMFINZI APPROVED IN JAPAN FOR STAGE III NSCLC Foreign Filer Report	2018-07-02	English
Lynparza approved in Japan for BRCAm breast cancer Regulatory Filings	2018-07-02	English
Imfinzi approved in Japan for Stage III nsclc Earnings Release Q2 2018	2018-07-02	English
BYDUREON RECEIVES POSITIVE CHMP OPINION FOR BCISE Foreign Filer Report	2018-06-29	English
Bydureon receives positive CHMP opinion for BCise Regulatory Filings	2018-06-29	English
AZ and Luye Pharma complete agreement for Seroquel M&A Activity	2018-06-28	English
AZ AND LUYE PHARMA COMPLETE AGREEMENT FOR SEROQUEL Foreign Filer Report	2018-06-28	English
LYNPARZA: SIGNIFICANT PFS 1ST-LINE OVARIAN CANCER Foreign Filer Report	2018-06-27	English
Lynparza: significant PFS 1st-line ovarian cancer Earnings Release FY 2018	2018-06-27	English
BOARD COMMITTEE CHANGES Foreign Filer Report	2018-06-26	English
Board Committee Changes Board/Management Information	2018-06-26	English
PUBLICATION OF A PROSPECTUS Foreign Filer Report	2018-06-22	English
Publication of a Prospectus Regulatory Filings	2018-06-22	English
Publication of Base Prospectus Capital/Financing Update	2018-06-21	English
UPDATE: LANABECESTAT PHASE III ALZHEIMER'S TRIALS Foreign Filer Report	2018-06-12	English
Update: lanabecestat Phase III Alzheimer's trials Legal Proceedings Report	2018-06-12	English
EU APPROVES TAGRISSO FOR 1ST-LINE NSCLC Regulatory Filings	2018-06-08	English
EU APPROVES TAGRISSO FOR 1ST-LINE NSCLC Foreign Filer Report	2018-06-08	English
DIRECTOR DECLARATION Foreign Filer Report	2018-06-08	English
Director Declaration Board/Management Information	2018-06-08	English
Block listing Interim Review Remuneration Information	2018-06-01	English
Total Voting Rights Regulatory Filings	2018-06-01	English
Director Declaration Board/Management Information	2018-06-01	English
6-K Filing Foreign Filer Report	2018-06-01	English
6-K Filing Foreign Filer Report	2018-06-01	English
6-K Filing Foreign Filer Report	2018-06-01	English
Update on TERRANOVA PIII trial for Fasenra in COPD Regulatory Filings	2018-05-30	English
6-K Filing Foreign Filer Report	2018-05-30	English
AZ's Imfinzi: significant OS in Stage III nsclc Regulatory Filings	2018-05-25	English
6-K Filing Foreign Filer Report	2018-05-25	English
AZ regulatory submission in Japan for Forxiga Regulatory Filings	2018-05-21	English
US FDA approves Lokelma for adult hyperkalaemia Regulatory Filings	2018-05-21	English
6-K Filing Foreign Filer Report	2018-05-21	English
6-K Filing Foreign Filer Report	2018-05-21	English
AZN: Q1 2018 Results Earnings Release Q1 2018	2018-05-18	English
6-K Filing Foreign Filer Report	2018-05-18	English
6-K Filing Foreign Filer Report	2018-05-18	English
Special Business Approved at AGM AGM Information	2018-05-18	English
AstraZeneca update on Fasenra PIII trial in COPD Regulatory Filings	2018-05-11	English
6-K Filing Foreign Filer Report	2018-05-11	English
EMA approves Lynparza: maintenance ovarian cancer Regulatory Filings	2018-05-08	English
AZ and Luye Pharma enter agreement for Seroquel M&A Activity	2018-05-08	English
6-K Filing Foreign Filer Report	2018-05-08	English
6-K Filing Foreign Filer Report	2018-05-07	English
Director Declaration Board/Management Information	2018-05-04	English
6-K Filing Foreign Filer Report	2018-05-04	English
Total Voting Rights Regulatory Filings	2018-05-01	English
6-K Filing Foreign Filer Report	2018-05-01	English
AZ: positive CHMP for Tagrisso first-line nsclc Regulatory Filings	2018-04-27	English
6-K Filing Foreign Filer Report	2018-04-27	English
AstraZeneca:high level results of the ARCTIC trial Regulatory Filings	2018-04-24	English
Issue of Equity - AstraZeneca Capital/Financing Update	2018-04-24	English
6-K Filing Foreign Filer Report	2018-04-24	English
FDA approves Tagrisso for 1st-line use in NSCLC Regulatory Filings	2018-04-19	English
6-K Filing Foreign Filer Report	2018-04-19	English
Notice of AGM AGM Information	2018-04-13	English
6-K Filing Foreign Filer Report	2018-04-13	English
6-K Filing Foreign Filer Report	2018-04-13	English
AGM Notice Proxy Solicitation & Information Statement	2018-04-13	English
Proxy Form AGM Information	2018-04-13	English
Directorate Change Board/Management Information	2018-04-05	English
6-K Filing Foreign Filer Report	2018-04-05	English
Total Voting Rights Regulatory Filings	2018-04-03	English
6-K Filing Foreign Filer Report	2018-04-03	English
6-K Filing Foreign Filer Report	2018-04-03	English
6-K Filing Foreign Filer Report	2018-04-03	English
Director/PDMR Shareholding Director's Dealing	2018-03-28	English
6-K Filing Foreign Filer Report	2018-03-28	English
Director/PDMR Shareholding Remuneration Information	2018-03-26	English
6-K Filing Foreign Filer Report	2018-03-26	English
Lokelma approved in the EU Regulatory Filings	2018-03-22	English
6-K Filing Foreign Filer Report	2018-03-22	English
ASTRAZENECA UPDATES MYSTIC TRIAL TIMELINE Regulatory Filings	2018-03-12	English
6-K Filing Foreign Filer Report	2018-03-12	English
Filing of Form 20-F with SEC Report Publication Announcement	2018-03-07	English
6-K Filing Foreign Filer Report	2018-03-07	English
Annual Financial Report Report Publication Announcement	2018-03-06	English
20-F Filing Annual Report FY 2017	2018-03-06	English
6-K Filing Foreign Filer Report	2018-03-06	English
IRANNOTICE Filing Regulatory Filings	2018-03-06	English
Total Voting Rights Regulatory Filings	2018-03-01	English
6-K Filing Foreign Filer Report	2018-03-01	English
Lynparza CHMP for ovarian cancer maintainance Regulatory Filings	2018-02-23	English
6-K Filing Foreign Filer Report	2018-02-23	English
6-K Filing Foreign Filer Report	2018-02-20	English
AstraZeneca's IMFINZI approved for Stage III nsclc Regulatory Filings	2018-02-19	English
Selumetinib in NF1 gets FDA orphan drug status Regulatory Filings	2018-02-15	English
6-K Filing Foreign Filer Report	2018-02-15	English
SC 13G Filing Major Shareholding Notification	2018-02-08	English
SC 13G/A Filing Major Shareholding Notification	2018-02-08	English
Director/PDMR Shareholding Director's Dealing	2018-02-05	English
6-K Filing Foreign Filer Report	2018-02-05	English
AZN: Full-Year 2017 Results Earnings Release FY 2017	2018-02-02	English
6-K Filing Foreign Filer Report	2018-02-02	English
Total Voting Rights Regulatory Filings	2018-02-01	English
6-K Filing Foreign Filer Report	2018-02-01	English
SC 13G/A Filing Major Shareholding Notification	2018-01-30	English
AZ Reports Phase III Results for PT010 in COPD Regulatory Filings	2018-01-26	English
AZ Reports Phase III Results for PT010 in COPD Regulatory Filings	2018-01-26	English
6-K/A Filing Foreign Filer Report	2018-01-26	English
6-K Filing Foreign Filer Report	2018-01-26	English
LYNPARZA APPROVED IN JAPAN FOR OVARIAN CANCER Regulatory Filings	2018-01-19	English
ASTRAZENECA'S FASENRA RECEIVES APPROVAL IN JAPAN Regulatory Filings	2018-01-19	English
6-K Filing Foreign Filer Report	2018-01-19	English
6-K Filing Foreign Filer Report	2018-01-19	English
FDA approves Lynparza for metastatic breast cancer Regulatory Filings	2018-01-12	English
6-K Filing Foreign Filer Report	2018-01-12	English
AstraZeneca's Fasenra approved in the EU Regulatory Filings	2018-01-10	English
6-K Filing Foreign Filer Report	2018-01-10	English
Total Voting Rights Regulatory Filings	2018-01-02	English
6-K Filing Foreign Filer Report	2018-01-02	English

Filings by year

2026 85 filings
2025 244 filings
2024 214 filings
2023 196 filings
2022 252 filings
2021 318 filings
2020 306 filings
2019 250 filings
2018 226 filings
2017 189 filings
2016 207 filings
2015 192 filings
2014 352 filings
2013 195 filings
2012 42 filings
2011 19 filings
2010 17 filings